Table 1.
The characteristics of the included studies.
| Author | Year | Country | Instrument | Sample size | Aged(Years) | Type of Study | Prevalence | Influence factor | Quality assessment |
|---|---|---|---|---|---|---|---|---|---|
| Villarreal Garza C et al. (12) | 2017 | Mexico | FIS | 134 | 34.6 | Cross-sectional | 44% | CDFGHIJ | 8 |
| Gorman JR et al. (13) | 2010 | USA | RCS | 131 | 36.7 | Cross-sectional | 64% | AFG | 8 |
| Ba´rtolo A et al. (16) | 2019 | Portuguesa | RACA | 104 | 36.1 ± 3.03 | Cross-sectional | 36% | K | 6 |
| LjungmanL et al. (17) | 2018 | Sweden | RACA | 181 | 34.6 ± 4.1 | Cross-sectional | 56% | BFIJ | 9 |
| Ruggeria M et al. (18) | 2014 | Switzerland Italy |
RACA | 297 | 18-40 | Cohort study | 58% | ABCDEGHIJL | 8 |
| Ruddy KJ et al. (19) | 2014 | USA | FIS | 620 | 17-40 | Cohort study | 51% | ABCDEGHIJKL | 8 |
| Jiajia Qiu et al. (20) | 2022 | China | RACA | 112 | 21-40 | Cross-sectional | – | ABG | 6 |
A, age; B, education; C, With partner; D, economic; E, genetic; F, desire to have children; G, >1 child; H, surgery; I, chemotherapy; J, endocrine therapy; K, depression; L, full-time job FIS, Fertility Issues and Outcomes Scale; RCAC, Reproductive Concerns After Cancer Scale; RCS, reproductive concerns scale.
"–", No data available.